Can radiation therapy and cremation safely coexist?

An increasing number of cancer patients are undergoing advanced radiation therapy...Read more on AuntMinnie.comRelated Reading: Ontario ban on cremation after brachytherapy draws scrutiny ACR, AAPM address radiation incident in Ariz. crematory Radiotracer contaminates crematorium after patient dies Brachytherapy error halts treatment at Canadian center SNMMI: New therapy aids patients with neuroendocrine tumors
Source: Headlines - Category: Radiology Source Type: news

Related Links:

Publication date: Available online 14 March 2019Source: The Lancet HIVAuthor(s): Evgeny Krupitsky, Elena Blokhina, Edwin Zvartau, Elena Verbitskaya, Dmitri Lioznov, Tatiana Yaroslavtseva, Vladimir Palatkin, Marina Vetrova, Natalia Bushara, Andrei Burakov, Dmitri Masalov, Olga Mamontova, Daniel Langleben, Sabrina Poole, Robert Gross, George WoodySummaryBackgroundUntreated opioid addiction in people with HIV is associated with poor HIV treatment outcomes. Slow-release, long-acting, implantable naltrexone might improve these outcomes. Here, we present results of a study aimed to test this hypothesis.MethodsWe did a 48 week do...
Source: The Lancet HIV - Category: Infectious Diseases Source Type: research
Publication date: Available online 15 March 2019Source: Journal of Pharmaceutical and Biomedical AnalysisAuthor(s): Tingting Wang, Lei Yin, Hao Wang, John Paul Fawcett, Jingkai GuAbstractThymosin α1 (Thymalfasin, Tα1) is a naturally occurring polypeptide widely used as an immune system enhancer for the treatment of HIV/AIDS, hepatitis B and C, and cancer. Recombinant human Tα1 (rh-Tα1) lacking N-terminal acetylation (NTA) displays similar biological activity to Tα1 and has completed phase III clinical trials in China. To compare the pharmacokinetics of rh-Tα1 and Tα1 and establish ...
Source: Journal of Pharmaceutical and Biomedical Analysis - Category: Drugs & Pharmacology Source Type: research
For over 10 years, one of the cornerstones of the Medicare Part D program has been to ensure the sickest and most vulnerable patients have access to the clinically critical medicines they rely on. For the patients whose treatment is covered under six specific classes of medicines – those with HIV, cancer and epilepsy among others – more commonly known as the six protected classes, there is no “one size fits all” for medicines that will work. The medicines for these patients have complex interactions, side effects, contraindications and other factors that must be cons idered in their coverage.
Source: The Catalyst - Category: Pharmaceuticals Authors: Tags: HIV/AIDS Part D Prescription for Medicare Source Type: news
Shared decision-making in oncology requires information on individual prognosis. This comprises cancer prognosis as well as competing risks of dying due to age and comorbidities. Decision aids usually do not p...
Source: BMC Health Services Research - Category: General Medicine Authors: Tags: Research article Source Type: research
Conclusions: High-level evidence is not always the main consideration when adopting new tools into practice. And yet, understanding how clinicians and health system decision-makers decide whether and how to adopt new tools is important to optimizing the use of new tools and practices that are supported by research evidence. PMID: 30853794 [PubMed - in process]
Source: Current Oncology - Category: Cancer & Oncology Tags: Curr Oncol Source Type: research
President Donald Trump’s proposed 2020 budget includes nearly $300 million meant to “defeat the HIV/AIDS epidemic” in the U.S. — even as it calls for a 12% reduction in total funding to the Department of Health and Human Services (HHS). During his February State of the Union address, Trump announced an ambitious plan to “eliminate the HIV epidemic in the United States within 10 years.” During a subsequent call with reporters, health officials said the initiative would focus on 48 at-risk counties across the country and would involve promoting early HIV treatment and diagnosis, expanding ...
Source: TIME: Health - Category: Consumer Health News Authors: Tags: Uncategorized HIV/AIDS Source Type: news
Using PET/CT for follow-up at a later interval than what's recommended by existing...Read more on AuntMinnie.comRelated Reading: FDG-PET/CT aids in melanoma treatment assessment CT lung screening can catch recurring head, neck cancer ASTRO: Blood test confirms HPV-related cancer remission FDG-PET/CT fails for peripheral T-cell lymphoma outcomes FDG-PET/CT helps stage men with breast cancer, too
Source: Headlines - Category: Radiology Source Type: news
Researchers have developed a new FDG-PET/CT-based approach to better monitor...Read more on AuntMinnie.comRelated Reading: New PET tracer could aid melanoma detection FDG-PET/CT fails for peripheral T-cell lymphoma outcomes PET/CT predicts success of rad therapy for spinal mets FDG-PET/CT helps stage men with breast cancer, too PET/CT makes case for directing cervical cancer treatment
Source: Headlines - Category: Radiology Source Type: news
(University of Washington Health Sciences/UW Medicine) A first-of-its-kind nanoparticle vaccine candidate for respiratory syncytial virus, a major cause of infant mortality worldwide, has been developed through computer design. Animal tests suggest the vaccine could provide potent, durable protection against RSV. The vaccine is being further developed for possible clinical trials. The nanoparticle platform will also be used to design potential vaccines for AIDS, hepatitis C and cancer.
Source: EurekAlert! - Infectious and Emerging Diseases - Category: Infectious Diseases Source Type: news
ConclusionDue to these promising results, these extracts should be further investigated and tested on different strains of C. albicans and G. candidum towards validation of their efficacy as a natural drug.
Source: Journal of Medical Mycology - Category: Biology Source Type: research
More News: Brachytherapy | Brain | Canada Health | Cancer | Cancer & Oncology | HIV AIDS | Neurology | Radiation Therapy | Radiology